With Fujitsu’s consensus revenue growth and future P/E remaining virtually unchanged, the analyst fair value estimate saw only a slight increase, with the price target rising marginally from ¥3,705 to ¥3,765.
What's in the News
- Fujitsu partnered with UL Solutions to help Japanese companies comply with new climate reporting standards, leveraging ULTRUS ESG software and Fujitsu’s local expertise.
- Fujitsu and Acer Medical are co-developing “aiGait,” using advanced AI skeleton recognition to detect gait abnormalities for early diagnosis of dementia and Parkinson's, with initial rollout in Taiwan.
- Fujitsu enhanced its Uvance Wayfinders consulting business, focusing on AI-driven solutions for business transformation across industries, emphasizing continuous, autonomous management evolution.
- Fujitsu developed AI avatar technology for automated, multilingual presentations and Q&A, launching corporate trials and planning global availability as “Fujitsu AI Auto Presentation” integrated with Microsoft 365.
Valuation Changes
Summary of Valuation Changes for Fujitsu
- The Consensus Analyst Price Target remained effectively unchanged, moving only marginally from ¥3705 to ¥3765.
- The Consensus Revenue Growth forecasts for Fujitsu remained effectively unchanged, at 2.6% per annum.
- The Future P/E for Fujitsu remained effectively unchanged, moving only marginally from 22.06x to 22.31x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.